Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001525904 | SCV001736110 | likely benign | Cardiomyopathy | 2021-02-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002568115 | SCV002448522 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-11-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002449355 | SCV002612409 | likely benign | Cardiovascular phenotype | 2021-01-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004804224 | SCV005426685 | likely benign | Catecholaminergic polymorphic ventricular tachycardia | 2024-07-29 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001701192 | SCV001923826 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001726579 | SCV001966170 | likely benign | not provided | no assertion criteria provided | clinical testing |